You have 9 free searches left this month | for more free features.

Doxorubicin

Showing 26 - 50 of 2,767

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Breast Cancer Trial in Seoul (Extracorporeal shock waves)

Recruiting
  • Breast Cancer
  • Extracorporeal shock waves
  • Seoul, Yangcheon Gu, Korea, Republic of
    Kiwhan Kim
Oct 25, 2022

Basal Cell Carcinoma Trial in Aventura (Placebo-containing MNA, 25 µg doxorubicin-containing MNA, 50 µg doxorubicin-containing

Terminated
  • Basal Cell Carcinoma
  • Placebo-containing MNA
  • +4 more
  • Aventura, Florida
    The Center for Clinical and Cosmetic Research
Aug 16, 2022

Ovarian Cancer Recurrent Trial in Beijing (IN10018, Placebo of IN10018, Pegylated Liposomal Doxorubicin)

Recruiting
  • Ovarian Cancer Recurrent
  • Beijing, China
    Cancer Hospital Chinese Academy of Medical Science and Peking Un
Aug 23, 2023

Colon Cancer Liver Metastasis Trial in United States (Lyso-Thermosensitive Liposomal Doxorubicin, 5% Dextrose Solution,

Terminated
  • Colon Cancer Liver Metastasis
  • Lyso-Thermosensitive Liposomal Doxorubicin
  • +2 more
  • Los Angeles, California
  • +3 more
Sep 15, 2022

Desmoid Tumor Trial in GuangZhou (Liposome doxorubicin, Saline Solution)

Recruiting
  • Desmoid Tumor
  • Liposome doxorubicin
  • Saline Solution
  • GuangZhou, Guangdong, China
    Sun Yat-sen University cancer center
Sep 29, 2022

Angiosarcoma Metastatic Trial in Guangzhou (Abraxane combined with liposomal doxorubicin)

Recruiting
  • Angiosarcoma Metastatic
  • Abraxane combined with liposomal doxorubicin
  • Guangzhou, Guangdong, China
    Xing Zhang
Sep 4, 2022

Breast Cancer Trial in New York (Coenzyme Q10, Coenzyme Q10 Placebo)

Completed
  • Breast Cancer
  • New York, New York
    Columbia University Medical Center
Oct 13, 2022

Soft Tissue Sarcoma, Adult, Soft Tissue Sarcoma, Child Trial in Charlotte (Pembrolizumab, Doxorubicin)

Active, not recruiting
  • Soft Tissue Sarcoma, Adult
  • Soft Tissue Sarcoma, Child
  • Charlotte, North Carolina
    Levine Cancer Institute
Sep 29, 2022

Recurrent Ovarian Cancer Trial (DOXIL, Withaferin A, Ashwagandha)

Not yet recruiting
  • Recurrent Ovarian Cancer
  • (no location specified)
Jan 27, 2023

Advanced Soft-tissue Sarcoma, Metastatic Soft-tissue Sarcoma Trial in Toulouse (Doxorubicin, Cyclophosphamide)

Recruiting
  • Advanced Soft-tissue Sarcoma
  • Metastatic Soft-tissue Sarcoma
  • Toulouse, France
    Institut Claudius Reagaud-IUCT Oncopôle
Oct 6, 2022

Triple Negative Breast Cancer (TNBC) Trial in United States (Combination of liposomal doxorubicin)

Not yet recruiting
  • Triple Negative Breast Cancer (TNBC)
  • Combination of liposomal doxorubicin
  • Elizabeth, New Jersey
  • +7 more
Jul 13, 2023

Relapsed Sarcomas Trial in Cleveland (Disulfiram, Copper Gluconate, Liposomal Doxorubicin (Doxil))

Not yet recruiting
  • Relapsed Sarcomas
  • Cleveland, Ohio
    Cleveland Clinic, Case Comprehensive Cancer Center
Apr 18, 2022

Genetic and Epigenetic Factors on Clinical Response and Toxicity

Recruiting
  • Breast Cancer
    • Cairo, Egypt
      Ain Shams University
    Feb 8, 2023

    Hepatocellular Carcinoma Non-resectable Trial in Belgium, Germany, Italy (BioPearl™)

    Not yet recruiting
    • Hepatocellular Carcinoma Non-resectable
    • BioPearl™
    • Brussels, Belgium
    • +5 more
    Jun 20, 2023

    Solid Tumor, Urethral Cancer Trial in Houston (Bortezomib, Gemcitabine, Doxorubicin)

    Active, not recruiting
    • Solid Tumor
    • Urethral Cancer
    • Houston, Texas
      University of Texas MD Anderson Cancer Center
    Sep 22, 2022

    Adrenocortical Carcinoma Trial in Brescia (Etoposide, doxorubicin, cisplatin and Mitotane plus Megestrol Acetate 160 MG,

    Recruiting
    • Adrenocortical Carcinoma
    • Etoposide, doxorubicin, cisplatin and Mitotane plus Megestrol Acetate 160 MG
    • Etoposide, doxorubicin, cisplatin and Mitotane plus Placebo
    • Brescia, Italy
      Alfredo Berruti
    Jun 12, 2023

    Advanced Soft-tissue Sarcoma Trial in Nicosia, Amman (Doxorubicin, Cyclophosphamide Oral Product, Prednisolone)

    Recruiting
    • Advanced Soft-tissue Sarcoma
    • Doxorubicin
    • +3 more
    • Nicosia, Cyprus
    • +1 more
    Jul 1, 2022

    Cutaneous T Cell Lymphoma Trial in Pittsburgh (Micro needle array-Doxorubicin (MNA-D))

    Recruiting
    • Cutaneous T Cell Lymphoma
    • Micro needle array-Doxorubicin (MNA-D)
    • Pittsburgh, Pennsylvania
      University Of Pittsburgh Medical Center
    Jun 2, 2022

    Fallopian Tube Carcinosarcoma, Fallopian Tube Clear Cell Adenocarcinoma, Fallopian Tube Endometrioid Adenocarcinoma Trial in

    Recruiting
    • Fallopian Tube Carcinosarcoma
    • +28 more
    • Pegylated Liposomal Doxorubicin Hydrochloride
    • Peposertib
    • Aurora, Colorado
    • +7 more
    Sep 2, 2022

    Rhabdomyosarcoma, Child Trial (Doxorubicin Hydrochloride Liposome+Irinotecan, Temozolomide+Irinotecan+Vincristine)

    Not yet recruiting
    • Rhabdomyosarcoma, Child
    • (no location specified)
    Jul 13, 2022

    Advanced Malignant Tumors Trial in Shanghai (doxorubicin HCl liposome injection)

    Recruiting
    • Advanced Malignant Tumors
    • doxorubicin hydrochloride liposome injection
    • Shanghai, Shanghai, China
      Fudan University Shanghai Cancer Center
    Apr 28, 2022

    Recurrent Fallopian Tube Carcinoma, Recurrent Ovarian Carcinoma, Recurrent Primary Peritoneal Carcinoma Trial in Phoenix,

    Recruiting
    • Recurrent Fallopian Tube Carcinoma
    • +2 more
    • Bevacizumab
    • +4 more
    • Phoenix, Arizona
    • +2 more
    Jun 27, 2022

    Sarcoma Trial in Seoul (Durvalumab+doxorubicin cobination)

    Active, not recruiting
    • Sarcoma
    • Durvalumab+doxorubicin cobination
    • Seoul, Korea, Republic of
      Severance Hospital, Yonsei University Health System
    May 30, 2022

    Ovarian Cancer Trial in Pittsburgh (Pembrolizumab, ALX148, Doxorubicin)

    Not yet recruiting
    • Ovarian Cancer
    • Pittsburgh, Pennsylvania
      UPMC Hillman Cancer Center
    Jul 19, 2022

    Advanced Soft Tissue Sarcoma, Locally Advanced Angiosarcoma, Locally Advanced Leiomyosarcoma Trial in Portland (Doxorubicin

    Active, not recruiting
    • Advanced Soft Tissue Sarcoma
    • +26 more
    • Doxorubicin Hydrochloride
    • +3 more
    • Portland, Oregon
      OHSU Knight Cancer Institute
    Jan 6, 2023